Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3

Watchlist Manager
Ouro Fino Saude Animal Participacoes SA Logo
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
Watchlist
Price: 19.53 BRL 0.41%
Market Cap: 1.1B BRL
Have any thoughts about
Ouro Fino Saude Animal Participacoes SA?
Write Note

Relative Value

The Relative Value of one OFSA3 stock under the Base Case scenario is 40.77 BRL. Compared to the current market price of 19.53 BRL, Ouro Fino Saude Animal Participacoes SA is Undervalued by 52%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OFSA3 Relative Value
Base Case
40.77 BRL
Undervaluation 52%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
84
vs Industry
68
Median 3Y
1.3
Median 5Y
1.4
Industry
2.5
Forward
0.9
vs History
47
vs Industry
4
Median 3Y
10.7
Median 5Y
12.3
Industry
21.8
Forward
10.1
vs History
49
vs Industry
44
Median 3Y
15.1
Median 5Y
17.3
Industry
16.1
vs History
vs Industry
31
Median 3Y
8
Median 5Y
13.7
Industry
23.8
vs History
82
vs Industry
48
Median 3Y
1.8
Median 5Y
2
Industry
2.1
vs History
88
vs Industry
70
Median 3Y
1.4
Median 5Y
1.5
Industry
2.7
Forward
0.9
vs History
90
vs Industry
67
Median 3Y
2.8
Median 5Y
3
Industry
5.2
vs History
90
vs Industry
42
Median 3Y
7.6
Median 5Y
8.2
Industry
13.5
Forward
4.5
vs History
92
vs Industry
40
Median 3Y
9.2
Median 5Y
10
Industry
16.8
Forward
5.3
vs History
55
vs Industry
45
Median 3Y
16.3
Median 5Y
18
Industry
15.2
vs History
23
vs Industry
31
Median 3Y
9.5
Median 5Y
18.9
Industry
19.3
vs History
79
vs Industry
52
Median 3Y
1.3
Median 5Y
1.5
Industry
1.9

Multiples Across Competitors

OFSA3 Competitors Multiples
Ouro Fino Saude Animal Participacoes SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
1.1B BRL 1.1 11.6 5.7 7.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
749.1B USD 18.5 89.9 48.1 53.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
2.7T DKK 10.2 29 20.2 23
US
Johnson & Johnson
NYSE:JNJ
348B USD 4 23.7 11.5 14.9
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
200.1B CHF 3.4 17.4 9.8 11.6
UK
AstraZeneca PLC
LSE:AZN
161.8B GBP 4.1 31.5 169.4 253.8
CH
Novartis AG
SIX:NOVN
171.5B CHF 3.8 10.8 9.4 13.1
US
Pfizer Inc
NYSE:PFE
150.1B USD 2.5 35.4 10.5 15.9
P/E Multiple
Earnings Growth P/E to Growth
BR
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
Average P/E: 30
11.6
N/A N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
89.9
446%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
29
86%
0.3
US
Johnson & Johnson
NYSE:JNJ
23.7
-23%
N/A
US
Merck & Co Inc
NYSE:MRK
20.7
7 300%
0
CH
Roche Holding AG
SIX:ROG
17.4
54%
0.3
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
0.2
CH
Novartis AG
SIX:NOVN
10.8
31%
0.3
US
Pfizer Inc
NYSE:PFE
35.4
719%
0
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
BR
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
Average EV/EBITDA: 414.1
5.7
108%
0.1
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 459 134.4 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
48.1
195%
0.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
151%
25.5
DK
Novo Nordisk A/S
CSE:NOVO B
20.2
84%
0.2
US
Johnson & Johnson
NYSE:JNJ
11.5
14%
0.8
US
Merck & Co Inc
NYSE:MRK
10.5
331%
0
CH
Roche Holding AG
SIX:ROG
9.8
23%
0.4
UK
AstraZeneca PLC
LSE:AZN
169.4
64%
2.7
CH
Novartis AG
SIX:NOVN
9.4
8%
1.2
US
Pfizer Inc
NYSE:PFE
10.5
31%
0.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
BR
Ouro Fino Saude Animal Participacoes SA
BOVESPA:OFSA3
Average EV/EBIT: 1 810.8
7.2
144%
0
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
53.7
211%
0.3
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
26.2
DK
Novo Nordisk A/S
CSE:NOVO B
23
83%
0.3
US
Johnson & Johnson
NYSE:JNJ
14.9
28%
0.5
US
Merck & Co Inc
NYSE:MRK
12.5
675%
0
CH
Roche Holding AG
SIX:ROG
11.6
28%
0.4
UK
AstraZeneca PLC
LSE:AZN
253.8
131%
1.9
CH
Novartis AG
SIX:NOVN
13.1
58%
0.2
US
Pfizer Inc
NYSE:PFE
15.9
68%
0.2

See Also

Discover More
Back to Top